Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (2): 145-151.doi: 10.3736/jcim20100209

• Original Experimental Research • Previous Articles     Next Articles

Effects of astilbin on maturation and immunologic function of mouse bone marrow-derived dendritic cells

 Shao-hua SONGa, Xiao-yun SHENb, Guo-shan DINGa, Fang LIUa, Zhen-meng WANGc, Zhi-ren FUa   

  1. a Organ Transplantation Center, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
    b Institute of Immunology, Second Military Medical University, Shanghai 200433, China
    c Department of Anesthesiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China
  • Received:2009-11-05 Accepted:2009-12-30 Online:2010-02-20 Published:2010-02-15
  • Contact: Zhi-ren FU


To explore the effects of astilbin on the maturation and immunologic function of mouse bone marrow-derived dendritic cells (DCs).

Mouse bone marrow cells were cultured with recombinant mouse granulocyte-macrophage colony-stimulating factor and interleukin-4 (IL-4) for 5 days to get immature DCs (imDCs), then the imDCs was cultured in the presence of 1 μg/mL lipopolysaccharide (LPS) or LPS (1 μg/mL) plus astilbin (25, 50, 100 μg/mL) for 48 h. Then, the cells were harvested, and the apoptosis, immunophenotypes and antigen phagocytosis capability of imDCs in LPS, and low-, medium- and high-dose astilbin groups were analyzed by flow cytometry. Contents of p40 subunit of interleukin-12 (IL-12p40) in the supernatants were detected with enzyme-linked immunosorbent assay (ELISA). The stimulatory activity of the harvested cells on allogeneic T cells in mixed lymphocyte reactions (MLR) was tested by incorporation of 3H-thymidine, and the contents of IL-2, IL-4, IL-10 and interferon-γ (INF-γ) in the supernatants of MLR were examined by ELISA.

At the concentrations of 25 to 100 μg/mL, astilbin exhibited no toxicity on co-cultured DCs. Compared with the lipopolysaccharide, low-, medium- and high-dose astilbin could decrease the expression levels of major histocompatibility complex-Ⅰa (MHC-Ⅰa), CD40, CD80 and CD86 molecules in DCs. DCs in the low-, medium- and high-dose astilbin groups exhibited weaker capabilities for antigen phagocytosis and less contents of IL-12p40 in the supernatants than in the LPS group. Furthermore, low-, medium- and high-dose astilbin showed weak activities in stimulating the proliferation of allogeneic T cells as compared with the LPS (P<0.05). Compared with the LPS, low-, medium- and high-dose astilbin could decrease IL-2 and INF-γ secretion from T cells in MLR but had no effect on IL-10 secretion.

Astilbin can inhibit maturation of mouse bone marrow-derived DCs with dose-dependent effect and exert negative effects on immunologic function of the DCs.

Key words: Astilbin, Dendritic cells, Immunologic function, Mice

Figure 1

Effects of astilbin on apoptosis of bone marrow dendritic cells"

Table 1

Expressions of MHC-Ⅰa and co-stimulatory molecules in DCs in different groups ($\bar{x}±s$, %)"

Group n MHC-Ⅰa CD40 CD80 CD86
imDC 4 38.24±5.68 22.89±3.18 26.79±3.55 36.22±5.17
Lipopolysaccharide 4 84.78±9.28** 60.69±6.16** 75.08±8.65** 60.33±7.25**
Low-dose astilbin 4 66.37±7.03 48.89±5.78 55.25±6.18 50.25±4.28
Medium-dose astilbin 4 60.59±5.38 45.38±3.97 50.72±5.19 47.43±3.89
High-dose astilbin 4 58.06±5.09 33.98±4.87 46.14±3.57 45.04±3.22

Figure 2

Effects of astilbin on antigen phagocytosis of DCs The phagocytic ability of DCs was tested by measuring FITC-dextran phagocytosis by using fluorescence-activated cell sorting. Right histograms represent DCs cultured with 25 μg/mL FITC-dextran at 37 ℃ for 2 h and are marked with geometric mean fluorescence intensity. Left histograms represent cells cultured with 25 μg/mL FITC-dextran at 4 ℃ for 2 h as a control. A: imDC group; B: Lipopolysaccharide group; C: Low-dose astilbin group; D: Medium-dose astilbin group; E: High-dose astilbin group."

Figure 3

Effects of astilbin on secretion of IL-12p40 from DCs A: imDC group; B: Lipopolysaccharide group; C: Low-dose astilbin group; D: Medium-dose astilbin group; E: High-dose astilbin group. Data were represented as x±s, n=4. **P<0.01, vs imDC group; △P<0.05, vs lipopolysaccharide group."


Group n Stimulatory cells︰responsive cells
DCs︰T cells =1︰5 DCs︰T cells =1︰10 DCs︰T cells =1︰20
imDC 4 26.25±2.35 20.16±2.29 18.90±1.15
Lipopolysaccharide 4 58.66±10.61** 50.22±9.26** 45.78±7.68**
Low-dose astilbin 4 40.15±6.24 38.57±5.24 35.68±4.48
Medium-dose astilbin 4 37.27±4.29 35.68±4.57 31.27±4.09
High-dose astilbin 4 36.02±5.99 33.98±4.87 30.148±3.98

Figure 4

Effects of astilbin on cytokine secretion from T cells in MLR when the proportion of DCs (Ratio of DCs to T cells) was 1︰10A: imDC group; B: Lipopolysaccharide group; C: Low-dose astilbin group; D: Medium-dose astilbin group; E: High-dose astilbin group. Data were represented as x±s, n=4. **P<0.01, vs imDC group; △P<0.05, vs lipopolysaccharide group."

[1] Di Nicola M, Lemoli RM . Dendritic cells: specialized antigen presenting cells[J]. Haematologica, 2000,85(2):202-207
[2] Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, Omori M, Zhou B, Ziegler SF . TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation[J]. Annu Rev Immunol, 2007,25:193-219
doi: 10.1146/annurev.immunol.25.022106.141718
[3] Han TH, Jin P, Ren J, Slezak S, Marincola FM, Stroncek DF . Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma[J]. J Immunother, 2009,32(4):399-407
doi: 10.1097/CJI.0b013e31819e1773
[4] Lee LF, Xu B, Michie SA, Beilhack GF, Warganich T, Turley S , McDevitt HO.The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation[J]. Proc Natl Acad Sci U S A, 2005,102(44):15995-16000
doi: 10.1073/pnas.0508122102
[5] Moser M . Dendritic cells in immunity and tolerance — do they display opposite functions?[J]. Immunity, 2003,19(1):5-8
doi: 10.1016/S1074-7613(03)00182-1
[6] Hou J, Wei JM, Yu ZY, Xu Y, Li J, Tang DN . The effect of malononitrilamides(FK778) on phenotypic properties of human peripheral dendritic cells[J]. Transplant Proc, 2009,41(5):1859-1861
doi: 10.1016/j.transproceed.2009.02.068
[7] Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A . Contrasting impacts of immunosuppressive agents(rapamycin, FK506, cyclosporine A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation[J]. J Immunol, 2002,169(7):3555-3564
doi: 10.4049/jimmunol.169.7.3555
[8] Gao SH, Li P, Chen T, Pan TC, Zhao JP . Effects of astilbin on the expression of IL-2, γ-IFN, IL-4, IL-10, IL-12 and IL-18 in mice heart transplantation rejection[J]. Zhonghua Xiao Er Wai Ke Za Zhi, 2006,27(2):87-89
高思海, 李平, 陈涛, 潘铁成, 赵金平 . 落新妇甙对心脏移植排斥反应中细胞因子表达的影响[J]. 中华小儿外科杂志, 2006,27(2):87-89
[9] Song SH, Shen XY, Liu F, Tang Y, Wang ZM, Fu ZR . Protective effects of astilbin on renal ischemia-reperfusion injury in rats[J]. J Chin Integr Med, 2009,7(8):753-757
宋少华, 沈筱芸, 刘芳, 唐乙, 王振猛, 傅志仁 . 落新妇苷对大鼠肾脏缺血再灌注损伤的保护作用[J]. 中西医结合学报, 2009,7(8):753-757
[10] Fu H, Song S, Liu F, Ni Z, Tang Y, Shen X, Xiao L, Ding G, Wang Q . Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival[J]. Cell Mol Immunol, 2009,6(2):87-95
doi: 10.1038/cmi.2009.12
[11] Haraguchi H, Mochida Y, Sakai S, Masuda H, Tamura Y, Mizutani K, Tanaka O, Chou WH . Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis[J]. Biosci Biotechnol Biochem, 1996,60(6):945-948
doi: 10.1271/bbb.60.945
[12] Moulari B, Pellequer Y, Lboutounne H, Girard C, Chaumont JP, Millet J, Muyard F . Isolation and in vitro antibacterial activity of astilbin, the bioactive flavanone from the leaves of Harungana madagascariensis Lam[J]. ex Poir.( Hypericaceae). J Ethnopharmacol, 2006,106(2):272-278
[13] Cechinel-Filho V, Vaz ZR, Zunino L, Calixto JB, Yunes RA . Antinociceptive and anti-oedematogenic properties of astilbin, taxifolin and some related compounds[J]. Arzneimittelforschung, 2000,50(3):281-285
[14] Xu Q, Wu F, Cao J, Chen T, Jiang J, Saiki I, Koda A . Astilbin selectively induces dysfunction of liver-infiltrating cells — novel protection from liver damage[J]. Eur J Pharmacol, 1999,377(1):93-100
doi: 10.1016/S0014-2999(99)00401-X
[15] Cai Y, Chen T, Xu Q . Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes[J]. Inflamm Res, 2003,52(8):334-340
doi: 10.1007/s00011-003-1179-3
[16] Yi HW, Lu XM, Fang F, Wang J, Xu Q . Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-alpha and its associated MMP-9 activity and CD44 expression[J]. Int Immunopharmacol, 2008,8(10):1467-1474
doi: 10.1016/j.intimp.2008.06.006
[17] Guo J, Qian F, Li J, Xu Q, Chen T . Identification of a new metabolite of astilbin, 3'-O-methylastilbin, and its immunosuppressive activity against contact dermatitis[J]. Clin Chem, 2007,53(3):465-471
doi: 10.1373/clinchem.2006.077297
[18] Yamazaki S, Steinman RM . Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells[J]. J Dermatol Sci, 2009,54(2):69-75
doi: 10.1016/j.jdermsci.2009.02.001
[19] Jiang H, van de Ven C, Baxi L, Satwani P, Cairo MS . Differential gene expression signatures of adult peripheral blood vs cord blood monocyte-derived immature and mature dendritic cells[J]. Exp Hematol, 2009,37(10):1201-1215
doi: 10.1016/j.exphem.2009.07.010
[20] Sallusto F, Lanzavecchia A . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha[J]. J Exp Med, 1994,179(4):1109-1118
doi: 10.1084/jem.179.4.1109
[21] Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V . Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells[J]. J Immunol, 2000,164(9):4443-4451
doi: 10.4049/jimmunol.164.9.4443
[22] Fu BM, He XS, Yu S, Hu AB, Ma Y, Wu LW, Tam NL, Huang JF . Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells[J]. Exp Clin Transplant, 2009,7(3):149-156
[1] Victor Abou Nehmi Filho, Gilson Masahiro Murata, Ruan Carlos Macêdo de Moraes, Gabriely Cristina Alves Lima, Danielle Araujo de Miranda, Katrin Radloff, Raquel Galvão Figuerêdo Costa, Joyce de Cassia Rosa de Jesus, Jéssica Alves De Freitas, Nayara Izabel Viana, Ruan Pimenta, Katia Ramos Moreira Leite, José Pinhata Otoch, Ana Flávia Marçal Pessoa. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice. Journal of Integrative Medicine, 2021, 19(5): 439-450.
[2] Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.
[3] Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[4] Bhesh Raj Sharma, Dong Wook Kim, Dong Young Rhyu. Korean Chungtaejeon tea extract attenuates weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2017, 15(1): 56-63.
[5] Shi-li Jiang, Xu-dong Hu, Ping Liu. Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice. Journal of Integrative Medicine, 2015, 13(4): 262-268.
[6] Elizabeth Abidemi Balogun, Sylvia Orume Malomo, Joseph Oluwatope Adebayo, Ahmed Adebayo Ishola, Ayodele Olufemi Soladoye, Lawrence Aderemi Olatunji, Olatunji Matthew Kolawole, Stephen Olubunmi Oguntoye, Abiola Samuel Babatunde, Oluwole Busayo Akinola . In vivo antimalarial activity and toxicological effects of methanolic extract of Cocos nucifera (Dwarf red variety) husk fibre. Journal of Integrative Medicine, 2014, 12(6): 504-511.
[7] Md. Asadujjaman, Ahmed Ullah Mishuk, Md. Aslam Hossain, Utpal Kumar Karmakar. Medicinal potential of Passiflora foetida L. plant extracts: Biological and pharmacological activities. Journal of Integrative Medicine, 2014, 12(2): 121-126.
[8] Marjan Nassiri-Asl, Taghi Naserpour Farivar, Esmail Abbasi, Hamid Reza Sadeghnia, Mehdi Sheikhi, Mina Lotfizadeh, Parisa Bazahang. Effects of rutin on oxidative stress in mice with kainic acid-induced seizure. Journal of Chinese Integrative Medicine, 2013, 11(5): 337-342.
[9] Md. Khirul Islam, Imran Mahmud, Sanjib Saha, Asit Baron Sarker, Himangsu Mondal, A.S.M. Monjur-Al-Hossain, Md. Anisuzzman. Preliminary pharmacological evaluation of Alocasia indica Schott tuber. Journal of Chinese Integrative Medicine, 2013, 11(5): 343-351.
[10] Sanjib Saha, Faroque Hossain, Md. Anisuzzman, Md. Khirul Islam. Pharmacological evaluation of Musa seminifera Lour. Fruit. Journal of Chinese Integrative Medicine, 2013, 11(4): 253-261.
[11] Sunil A. Nirmal, Jayashri M. Ingale, Shashikant R. Pattan, Sanjay B. Bhawar. Amaranthus roxburghianus root extract in combination with piperine as a potential treatment of ulcerative colitis in mice. Journal of Chinese Integrative Medicine, 2013, 11(3): 206-212.
[12] Mei-jiao Mao, Jun-ping Hu, Cong Wang, Yi-yi Zhang, Ping Liu. Effects of Chinese herbal medicine Guanxinkang on expression of PPARγ-LXRα-ABCA1 pathway in ApoE-knockout mice with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(7): 814-820.
[13] Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.
[14] Yi-tao Zhao , Xin-guang Zhang , Li Bai , Li-qing Li , Jian-er Yu . Effects of Chinese herbal medicine Pingchuan Formula on airway inflammation, interferon-γ and interleukin-4 in mice with asthma. Journal of Chinese Integrative Medicine, 2012, 10(7): 807-813.
[15] Dong-mei Zhang, Li-xia Lou, Ai-ming Wu, Xi-ying Lü, Zhao-juan Hu, Yan-hong Zhang, Hong-fang Liu. Effects of Astragalus membranaceus and Potentilla discolor mixture on insulin resistance and its related mRNA expressions in KKAy mice with type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(7): 821-826.
Full text



[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022